Source: Eur Respir Mon; 2004: 28: 45–63



Rating:

Share or cite this content

Citations should be made in the following way:
M.T. Labro. Interaction of antibacterial agents with host respiratory defences. Eur Respir Mon; 2004: 28: 45–63

Member's Comments

No comment yet.

Related content which might interest you: Innate immunity in the lung: how epithelial cells fight against respiratory pathogens Source: Eur Respir J 2004; 23: 327-333 Year: 2004 Cationic host defence peptides as a novel treatment for respiratory viral infections Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence Source: Eur Respir J 2015; 46: 771-782 Year: 2015 Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence Source: ERS Research Seminar 2015 Year: 2015 Improving the innate immune response in respiratory infections: the use of repurposed drugs Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Role of T- and B-;lymphocytes in pulmonary host defences Source: Eur Respir J 2001; 18: 846-856 Year: 2001 The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Impacts of inhaled corticosteroids on antiviral and antibacterial immunity in the lung Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Fluticasone propionate alters the respiratory tract microbiota and has dose-related effects on anti-bacterial host defence Source: International Congress 2016 – Translational research in respiratory infections Year: 2016 LSC Abstract – Interleukin-26 in antibacterial host defense of human lungs: Effects on neutrophil mobilization Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis Source: Eur Respir Mon 2011; 52: 11-21 Year: 2011 Macrolides have a role in respiratory infections beyond their antimicrobial activity? Source: Annual Congress 2010 - Highlights in respiratory infections Year: 2010 Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 Decreased innate immunity proteins in asthmatic respiratory tract lining fluids Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012